BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38628594)

  • 21. Helical tomotherapy in the treatment of pediatric malignancies: a preliminary report of feasibility and acute toxicity.
    Mesbah L; Matute R; Usychkin S; Marrone I; Puebla F; Mínguez C; García R; García G; Beltrán C; Marsiglia H
    Radiat Oncol; 2011 Aug; 6():102. PubMed ID: 21871078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study.
    Yock TI; Yeap BY; Ebb DH; Weyman E; Eaton BR; Sherry NA; Jones RM; MacDonald SM; Pulsifer MB; Lavally B; Abrams AN; Huang MS; Marcus KJ; Tarbell NJ
    Lancet Oncol; 2016 Mar; 17(3):287-298. PubMed ID: 26830377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival after chemotherapy and stem cell transplant followed by delayed craniospinal irradiation is comparable to upfront craniospinal irradiation in pediatric embryonal brain tumor patients.
    Raleigh DR; Tomlin B; Buono BD; Roddy E; Sear K; Byer L; Felton E; Banerjee A; Torkildson J; Samuel D; Horn B; Braunstein SE; Haas-Kogan DA; Mueller S
    J Neurooncol; 2017 Jan; 131(2):359-368. PubMed ID: 27778212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patients.
    Massimino M; Sunyach MP; Barretta F; Gandola L; Garegnani A; Pecori E; Spreafico F; Bonneville-Levard A; Meyronet D; Mottolese C; Boschetti L; Biassoni V; Schiavello E; Giussani C; Carrabba G; Diletto B; Pallotti F; Stefini R; Ferrari A; Terenziani M; Casanova M; Luksch R; Meazza C; Podda M; Chiaravalli S; Puma N; Bergamaschi L; Morosi C; Calareso G; Giangaspero F; Antonelli M; Buttarelli FR; Frappaz D
    J Neurooncol; 2020 Jul; 148(3):619-628. PubMed ID: 32567042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overall survival and secondary malignant neoplasms in children receiving passively scattered proton or photon craniospinal irradiation for medulloblastoma.
    Paulino AC; Ludmir EB; Grosshans DR; Su JM; McGovern SL; Okcu MF; McAleer MF; Baxter PA; Mahajan A; Chintagumpala MM
    Cancer; 2021 Oct; 127(20):3865-3871. PubMed ID: 34254296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tomotherapy for cranio-spinal irradiation.
    Turcas A; Kelly SM; Clementel E; Cernea D
    Clin Transl Radiat Oncol; 2023 Jan; 38():96-103. PubMed ID: 36407491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of long-term survivors of metastatic medulloblastoma treated with reduced-dose craniospinal irradiation.
    Irikura T; Fukuoka K; Nakazawa A; Ichimura K; Kurihara J; Koh K
    Childs Nerv Syst; 2023 Sep; 39(9):2505-2507. PubMed ID: 37185696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute toxicity and treatment interruption related to electron and photon craniospinal irradiation in pediatric patients treated at the University of Texas M. D. Anderson Cancer Center.
    Chang EL; Allen P; Wu C; Ater J; Kuttesch J; Maor MH
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1008-16. PubMed ID: 11958896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosimetric comparisons of craniospinal axis irradiation using helical tomotherapy, volume-modulated arc therapy and intensity-modulated radiotherapy for medulloblastoma.
    Sun Y; Liu G; Chen W; Chen T; Liu P; Zeng Q; Hong J; Wei R
    Transl Cancer Res; 2019 Feb; 8(1):191-202. PubMed ID: 35116748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pineoblastoma in Adults: A Rare Case Successfully Treated with Multimodal Approach Including Craniospinal Irradiation Using Helical Tomotherapy.
    Gaito S; Malagoli M; Depenni R; Pavesi G; Bruni A
    Cureus; 2019 Oct; 11(10):e5852. PubMed ID: 31754587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postponed is not canceled: role of craniospinal radiation therapy in the management of recurrent infant medulloblastoma--an experience from the HIT-REZ 1997 & 2005 studies.
    Müller K; Mynarek M; Zwiener I; Siegler N; Zimmermann M; Christiansen H; Budach W; Henke G; Warmuth-Metz M; Pietsch T; von Hoff K; von Bueren A; Bode U; Rutkowski S; Kortmann RD; Fleischhack G; Tippelt S
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1019-24. PubMed ID: 24661654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective study on dosimetric comparison of helical tomotherapy and 3DCRT for craniospinal irradiation - A single institution experience.
    Bandurska-Luque A; Piotrowski T; Skrobała A; Ryczkowski A; Adamska K; Kaźmierska J
    Rep Pract Oncol Radiother; 2015; 20(2):145-52. PubMed ID: 25859405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Craniospinal irradiation with concurrent temozolomide for primary metastatic pediatric high-grade or diffuse intrinsic pontine gliomas. A first report from the GPOH-HIT-HGG Study Group.
    Müller K; Schlamann A; Guckenberger M; Warmuth-Metz M; Glück A; Pietschmann S; Wawer A; Kortmann RD; Kramm C; von Bueren AO
    Strahlenther Onkol; 2014 Apr; 190(4):377-81. PubMed ID: 24638239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel preclinical model of craniospinal irradiation in pediatric diffuse midline glioma demonstrates decreased metastatic disease.
    Knox AJ; Van Court B; Oweida A; Barsh E; DeSisto J; Flannery P; Lemma R; Chatwin H; Vibhakar R; Dorris K; Serkova NJ; Karam SD; Gilani A; Green AL
    Front Oncol; 2023; 13():1105395. PubMed ID: 37124531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton versus photon craniospinal irradiation for adult medulloblastoma: A dosimetric, toxicity, and exploratory cost analysis.
    Breen WG; Geno CS; Waddle MR; Qian J; Harmsen WS; Burns TC; Sener UT; Ruff MW; Neth BJ; Uhm JH; Routman DM; Yan E; Kruse JJ; Laack NN; Brown PD; Mahajan A
    Neurooncol Adv; 2024; 6(1):vdae034. PubMed ID: 38550393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Craniospinal irradiation for treatment of metastatic pediatric low-grade glioma.
    Tsang DS; Murphy ES; Ezell SE; Lucas JT; Tinkle C; Merchant TE
    J Neurooncol; 2017 Sep; 134(2):317-324. PubMed ID: 28623604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome and prognostic factors following palliative craniospinal irradiation for leptomeningeal carcinomatosis.
    El Shafie RA; Böhm K; Weber D; Lang K; Schlaich F; Adeberg S; Paul A; Haefner MF; Katayama S; Sterzing F; Hörner-Rieber J; Löw S; Herfarth K; Debus J; Rieken S; Bernhardt D
    Cancer Manag Res; 2019; 11():789-801. PubMed ID: 30697071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma.
    Brown AP; Barney CL; Grosshans DR; McAleer MF; de Groot JF; Puduvalli VK; Tucker SL; Crawford CN; Khan M; Khatua S; Gilbert MR; Brown PD; Mahajan A
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):277-84. PubMed ID: 23433794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastoma.
    Luo LY; Kramer K; Cheung NV; Kushner BH; Modak S; Basu EM; Roberts SS; Wolden SL
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28364. PubMed ID: 32608559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salvage craniospinal irradiation for recurrent intracranial germinoma: a single institution analysis.
    Kanamori M; Shimoda Y; Umezawa R; Iizuka O; Mugikura S; Suzuki K; Ariga H; Jingu K; Saito R; Sonoda Y; Kumabe T; Tominaga T
    J Radiat Res; 2023 Mar; 64(2):428-437. PubMed ID: 36610798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.